Quantcast
Last updated on April 16, 2014 at 10:37 EDT

Latest Solta Medical Inc. Stories

2012-04-02 02:22:29

HAYWARD, Calif., April 2, 2012 /PRNewswire/ -- Solta Medical, Inc. (Nasdaq: SLTM), the pioneer in fractional resurfacing and non-invasive skin tightening and a global market leader in aesthetic treatments, introduced the second generation Liposonix system, its new non-invasive fat reduction device using high intensity focused ultrasound (HIFU), at the 10th Anti-aging Medicine World Congress (AMWC) in Monaco. Clinical studies have demonstrated an average waist circumference reduction of...

2012-03-19 02:24:46

HAYWARD, Calif., March 19, 2012 /PRNewswire/ -- Solta Medical, Inc. (NASDAQ: SLTM), a global leader in the medical aesthetics market, today announced that it will present at two upcoming investor conferences. Details of each follow: Maxim Group 2012 Growth ConferenceDate: Monday, March 26, 2012|Time: 11:30 am ETLocation: New York, NY Needham 11th Annual Healthcare ConferenceDate: Wednesday, April 4, 2012Time: 1:20 pm ETLocation: New York, NY Stephen J. Fanning, Chairman, President...

2012-03-07 05:30:00

HAYWARD, Calif., March 7, 2012 /PRNewswire/ -- Solta Medical, Inc. (NASDAQ: SLTM), a global leader in the medical aesthetics market, today provided an update on the launch of the second generation Liposonix non-invasive fat reduction system recently approved by the FDA. A majority of the Company's approximately twenty key opinion leaders (KOLs), comprised of leading plastic surgeons and dermatologists, who received Liposonix systems in mid-December as part of the pre-launch trial, have...

2012-03-05 12:27:00

HAYWARD, Calif., March 5, 2012 /PRNewswire/ -- Solta Medical, Inc. (NASDAQ: SLTM), a global leader in the medical aesthetics market, today announced that it will present at the 24th Annual ROTH Conference in Dana Point, CA, on Tuesday, March 13, 2012 at 2:00 pm Pacific Time. Stephen J. Fanning, Chairman, President and Chief Executive Officer, will review the company's business strategy and recent corporate events. Solta will offer a live audio webcast of the event which may be accessed at...

2012-02-13 15:00:00

HAYWARD, Calif., Feb. 13, 2012 /PRNewswire/ -- Solta Medical, Inc. (NASDAQ: SLTM), a global leader in the medical aesthetics market, today reported product revenue during the fourth quarter of 2011 grew 11% as compared with the quarter ended December 31, 2010. Sales of new systems and upgrades rose 14% to $15.9 million. Revenue from treatment tips and other consumables of $15.9 million grew $1.3 million, or 9%, as compared to the fourth quarter of 2010, and accounted for 48% of total...

2012-02-07 15:02:00

HAYWARD, Calif., Feb. 7, 2012 /PRNewswire/ -- Solta Medical, Inc. (NASDAQ: SLTM), a global leader in the medical aesthetics market, today announced that it will present at the Leerink Swann 2012 Global Healthcare Conference in New York City on Wednesday, February 15, 2012 at 2:30 pm Eastern Time. Stephen J. Fanning, Chairman, President and Chief Executive Officer, will give a brief presentation followed by a fireside chat on the company's business strategy, recent corporate events, and the...

2012-02-02 10:35:00

HAYWARD, Calif., Feb. 2, 2012 /PRNewswire/ -- Solta Medical, Inc. (Nasdaq: SLTM), a global leader in the medical aesthetics market, today confirmed its plan to release the Company's financial results for the fourth quarter ended December 31, 2011, after market close on Monday, February 13, 2012. The Company will also host a conference call and webcast on Monday, February 13, 2012, at 4:30 p.m. Eastern Time (1:30 p.m. Pacific) to discuss the financial results and current corporate...

2012-01-11 07:00:00

HAYWARD, Calif., Jan. 11, 2012 /PRNewswire/ -- Today, Solta Medical, Inc. (Nasdaq: SLTM), the pioneer in fractional resurfacing and non-invasive skin tightening and a global market leader in aesthetic treatments, announced the arrival of its groundbreaking Liposonix technology in the United States and Canada. Using advanced high-intensity focused ultrasound (HIFU) technology, Liposonix is a non-surgical permanent fat reduction procedure that has been clinically shown to slim down the...

2012-01-09 05:30:00

HAYWARD, Calif., Jan. 9, 2012 /PRNewswire/ -- Solta Medical, Inc. (NASDAQ: SLTM), a global leader in the medical aesthetics market, today reiterated the company's expectations for its financial results for the fourth quarter ended December 31, 2011 as follows: The company expects revenue for the fourth quarter of 2011 to be $32 million to $34 million. Revenue for the full year 2011 is expected to be in the range of $115 million to $117 million. Non-GAAP gross margin is...

2012-01-04 15:05:00

HAYWARD, Calif., Jan. 4, 2012 /PRNewswire/ -- Solta Medical, Inc. (NASDAQ: SLTM), a global leader in the medical aesthetics market, today announced that it will present at the 14th Annual Needham Growth Conference at the New York Palace Hotel in New York City on Thursday, January 12, 2012 at 10:00 am Eastern Time. Stephen J. Fanning, Chairman, President and Chief Executive Officer, will review the company's business strategy and recent corporate events. Attendance at this...